Aquatic exercises and health education for the treatment of fibromyalgia

INTERVENTION: E02.779.492 I02.233.332 Initially it was carried out an active recruitment of volunteers through direct contact with doctors, ads in newspapers and written disclosure in Basic Health Units (UBS) of Formiga ‐ MG. The first 46 volunteers who are interested in participating in the study and met the inclusion and exclusion criteria were enrolled in the study. The participants were randomly divided into two groups with a treaty in hydrotherapy and other in inter‐relational school of fibromyalgia. Seven questionnaires validity and reliability guaranteed for the Brazilian population were applied by an experienced evaluator who was unaware of the study objectives, as well as the treatment group they belonged to the participants. Questionnaires were: Pittsburgh Sleep Quality Index (PSQI); Inventory Beck Depression; Inventory Beck Anxiety; Piper Fatigue Scale; McGill Pain Questionnaire; Functional Independence Measure; Fibromyalgia Impact Questionnaire (FIQ) CONDITION: C05.651.324 Fibromyalgia ; C05.651.324 PRIMARY OUTCOME: Both hydrokinesiotherapy as the EIF are non‐pharmacological treatment strategies plausible for the management of patients with FM. At that you realize the hydrotherapy can improve the quality of sleep and anxiety levels, while the EIF can improve anxiety, depression and the impact caused by FM. Pittsburgh Sleep Quality Index (PSQI) for evaluation of sleep, the Beck Depression to assess depression, the Beck Anxiety to evaluate anxiety, Piper Fatigue Scale for assessing fatigue, McGill Pain Questionnaire for pain assessment, functional independence measure to evaluate the functionality and the fibromyalgia impact Questionnaire (FIQ) to evaluate the impact of fibromyalgia. Before during and after the intervention in hydrotherapy and in inter‐relational school of fibromyalgia. SECONDARY OUTCOME: Secondary outcomes are expected not INCLUSION CRITERIA: women who have a confirmed diagnosis of fibromyalgia by a physician and according to the new diagnostic criteria proposed by the American College of Rheumatology in 2011. Regardless of race; aged between 25 and 60 years; BMI below 30; who read and sign the Consent and Informed (IC) not using drugs for more than three months or with stable pharmacological treatment for more than three months.